or Try an Advanced Search...

    Technical Analysis for NPCE - Neuropace, Inc.

    Grade Last Price % Change Price Change
    F 6.91 5.66% 0.37
    NPCE closed up 5.66 percent on Friday, May 31, 2024, on 55 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical NPCE trend table...
    Date Alert Name Type % Chg
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 5.66%
    Down 3 Days in a Row Weakness 5.66%
    Down 4 Days in a Row Weakness 5.66%
    Down 5 Days in a Row Weakness 5.66%
    Oversold Stochastic Weakness 5.66%
    Narrow Range Bar Range Contraction 2.52%
    Wide Bands Range Expansion 2.52%
    Older End-of-Day Signals for NPCE ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day 1 day ago
    Up 5% 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    Up 3% 1 day ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NPCE Chart by TradingView
    Basic chart:

    Profile

    NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Neuroscience Epilepsy Neuromodulation Neurophysiology Neurotechnology Seizure Electroencephalography Brain–Computer Interfacing Neuroprosthetics

    Is NPCE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 27 NeuroPace, Inc.'s (NASDAQ:NPCE) top owners are private equity firms with 47% stake, while 24% is held by institutions
    May 14 NeuroPace to Participate in Two Healthcare Conferences in May
    May 13 NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript
    May 12 NeuroPace, Inc. (NPCE) Q1 2024 Earnings Call Transcript
    May 10 NeuroPace Inc (NPCE) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Ongoing Challenges
    May 9 NeuroPace Inc (NPCE) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ...
    May 8 NeuroPace GAAP EPS of -$0.32
    May 8 NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update
    Apr 17 NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
    Mar 27 NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
    See more NPCE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.15
    52 Week Low 3.825
    Average Volume 121,307
    200-Day Moving Average 10.60
    50-Day Moving Average 11.80
    20-Day Moving Average 8.93
    10-Day Moving Average 7.45
    Average True Range 0.74
    RSI (14) 25.93
    ADX 45.31
    +DI 7.54
    -DI 38.01
    Chandelier Exit (Long, 3 ATRs) 11.98
    Chandelier Exit (Short, 3 ATRs) 8.70
    Upper Bollinger Bands 13.45
    Lower Bollinger Band 4.41
    Percent B (%b) 0.28
    BandWidth 101.23
    MACD Line -1.58
    MACD Signal Line -1.50
    MACD Histogram -0.0745
    Fundamentals Value
    Market Cap 181.62 Million
    Num Shares 26.3 Million
    EPS -1.49
    Price-to-Earnings (P/E) Ratio -4.64
    Price-to-Sales 6.99
    Price-to-Book 27.16
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.56
    Resistance 3 (R3) 7.51 7.25 7.45
    Resistance 2 (R2) 7.25 7.09 7.27 7.41
    Resistance 1 (R1) 7.08 6.98 7.17 7.13 7.38
    Pivot Point 6.82 6.82 6.86 6.84 6.82
    Support 1 (S1) 6.65 6.66 6.74 6.70 6.44
    Support 2 (S2) 6.39 6.55 6.41 6.41
    Support 3 (S3) 6.22 6.39 6.37
    Support 4 (S4) 6.27